Modulating neuroinflammation with glucagon-like peptide-1 receptor agonists: a scoping review exploring their therapeutic potential in schizophrenia.

Otto B, Zantvoord JB, Siskind D, Vermeulen JM

Prog Neuropsychopharmacol Biol Psychiatry. 2026 Oct 16:111978. PMID: 42887669. Abstract